# Clinical Trials Support Services - Global Strategic Business Report 2026: Capitalize on $15 Billion in New Revenue by 2032 as IQVIA, ICON, Labcorp, Parexel and Veeva Disrupt Trials with AI

- Published: 2026-11-16
- Author: [Healthcare News](https://healthcarenews.io/author/healthcarenews-io.md)
- Topics: [News](https://healthcarenews.io/news.md)
- Source: https://healthcarenews.io/news/clinical-trials-support-services-global-strategic-business-report-2026-capitalize-on-15-bi/
- Publication: Healthcare News
- Publisher: Connectively (Terkel, Inc.)
- Editorial policy: https://healthcarenews.io/editorial-policy/

*Boost clinical trial ROI with AI analytics, decentralized trial tools and virtual patient support that cut costs, accelerate timelines, ensure compliance and improve retention.*

Dublin, Nov. 16, 2026 [(GLOBE NEWSWIRE)](https://www.globenewswire.com) -- <a href="https://www.researchandmarkets.com/reports/6069089/clinical-trials-support-services-global?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=2n2k9m&amp;utm_campaign=2404491+-+Clinical+Trials+Support+Services+-+Global+Strategic+Business+Report+2026%3a+Capitalize+on+%2415+Billion+in+New+Revenue+by+2032+as+IQVIA%2c+ICON%2c+Labcorp%2c+Parexel+and+Veeva+Disrupt+Trials+with+AI&amp;utm_exec=clshmsai" rel="nofollow">"Clinical Trials Support Services - Global Strategic Business Report 2026"</a> has been added to **ResearchAndMarkets.com's** offering.

**Global Clinical Trials Support Services Market to Reach US$38.2 Billion by 2032**

The global clinical trials support services market was valued at US$23.2 billion in 2025 and is projected to reach US$38.2 billion by 2032, expanding at a compound annual growth rate (CAGR) of 7.4%. Market growth is being supported by increasingly complex study protocols, stricter regulatory requirements, globalization of clinical research, and rising adoption of decentralized and hybrid clinical trial models.

Pharmaceutical, biopharmaceutical, and medical device companies are increasing their reliance on specialized clinical trial support service providers to improve study execution, maintain regulatory compliance, control costs, and accelerate development timelines. Demand spans clinical trial site management, patient recruitment, data management, administrative staffing, Institutional Review Board services, medical writing, regulatory support, and patient engagement.

**Technology Reshapes Clinical Trial Support Services**

Artificial intelligence, cloud-based platforms, blockchain-enabled regulatory tracking, and automated data verification are transforming clinical trial operations. AI-powered analytics and protocol optimization tools support study feasibility assessments, real-time decision-making, patient retention, and more responsive trial designs. Cloud-based document management systems also improve collaboration among sponsors, contract research organizations, investigators, and clinical sites.

Decentralized clinical trials are creating additional demand for remote site monitoring, electronic consent platforms, telehealth consultations, mobile health applications, and digital patient engagement solutions. These technologies can improve participant access and adherence while supporting continuous data collection across geographically dispersed study populations. Automated verification tools are also helping organizations reduce documentation errors and maintain alignment with Good Clinical Practice requirements.

**Clinical Trials Support Services Market Growth Drivers**

Key market drivers include expanding global clinical research activity, increased regulatory scrutiny, growing investment in digital health technologies, and demand for real-time clinical data analysis. Regulatory agencies continue to emphasize transparency, data integrity, participant protection, and consistent reporting, prompting sponsors to strengthen compliance-focused support capabilities.

The transition toward virtual, decentralized, and hybrid studies is expected to remain an important growth catalyst through 2032. As sponsors seek integrated solutions capable of supporting trials across multiple phases and jurisdictions, service providers with advanced technology platforms, international operating capabilities, and specialized therapeutic expertise are positioned to benefit.

**Market Segment and Regional Outlook**

-   **Phase Type:** Phase I, Phase II, Phase III, and Phase IV.
-   **Service Type:** Clinical trial site management, patient recruitment management, data management, administrative staffing, IRB services, and other support services.
-   **End Use:** Pharmaceutical and biopharmaceutical companies, medical device companies, and other organizations.

The Phase I segment is forecast to reach US$18.8 billion by 2032, advancing at an 8.4% CAGR. The Phase II segment is projected to grow at a 7.1% CAGR during the analysis period.

Regionally, the United States clinical trials support services market was valued at US$6.3 billion in 2025. China is forecast to expand at an 11.4% CAGR and reach US$8.3 billion by 2032. The report also evaluates market trends across Canada, Japan, Germany, France, Italy, the United Kingdom, Spain, Russia, Australia, India, South Korea, Latin America, the Middle East, Africa, and other major regional markets.

**Report Scope and Strategic Value**

The report provides independent analysis of annual market value and forecasts from 2025 through 2032. It examines competitive conditions, emerging revenue opportunities, regional market dynamics, segment growth trajectories, technology adoption, and the factors likely to influence future demand. It also addresses how the global clinical trials support services market may evolve, which segments are positioned for the strongest growth, and how competitive shares may change across key regions.

Featured companies include Celerion, Charles River Laboratories International Inc., Covance Inc., ICON plc, IQVIA, KCR, Labcorp Drug Development, Linical Co., Ltd., Medidata Solutions, Medpace Holdings Inc., Novotech, Parexel International Corporation, Pharm-Olam International, PPD, PRA Health Sciences, PSI CRO, Syneos Health, Veeva Systems, Worldwide Clinical Trials, and WuXi AppTec.

**Domain Expert Insights and Differentiation**

-   **Expert perspectives:** The analysis incorporates insights from specialists across industry, enterprise, and academia to provide context beyond conventional secondary research.
-   **Early market signals:** The report tracks developments emerging from expert discussions, corporate activity, conference sessions, keynotes, panel discussions, and market-relevant publications.
-   **Validated intelligence:** Findings draw on corporate disclosures, annual reports, institutional publications, industry events, and other verified sources.
-   **Strategic market direction:** The report connects market signals with competitive developments, investment priorities, technology trends, and long-term growth opportunities.
-   **Company intelligence:** Coverage extends beyond market-level forecasts to examine organizations influencing the clinical trials support services competitive landscape.
-   **Relevant market share analysis:** Competitive positioning is assessed across major geographic markets where regional structures and market dynamics require additional detail.

Complimentary report updates are provided for one year, enabling buyers to remain informed about significant developments affecting the global clinical trials support services market.

**Key Attributes:**  
  

| Report Attribute | Details |
| --- | --- |
| No. of Pages | 379 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value (USD) in 2025 | $23.2 Billion |
| Forecasted Market Value (USD) by 2032 | $38.2 Billion |
| Compound Annual Growth Rate | 7.4% |
| Regions Covered | Global |

  
For more information about this report visit <a href="https://www.researchandmarkets.com/reports/6069089/clinical-trials-support-services-global?utm_source=GNE&amp;utm_medium=PressRelease&amp;utm_code=2n2k9m&amp;utm_campaign=2404491+-+Clinical+Trials+Support+Services+-+Global+Strategic+Business+Report+2026%3a+Capitalize+on+%2415+Billion+in+New+Revenue+by+2032+as+IQVIA%2c+ICON%2c+Labcorp%2c+Parexel+and+Veeva+Disrupt+Trials+with+AI&amp;utm_exec=clshmsai" rel="nofollow">https://www.researchandmarkets.com/r/gt6en6</a>

**About ResearchAndMarkets.com**  
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: 
CONTACT: ResearchAndMarkets.com 
         Laura Wood,Senior Press Manager 
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470 
         For U.S./ CAN Toll Free Call 1-800-526-8630 
         For GMT Office Hours Call +353-1-416-8900 

  
![](https://ml.globenewswire.com/media/Yjg1YmZhNjEtYWQ3Yy00NGE4LWJmMTEtNjQ1MmUwZTMzZDM5LTEwMjY3MzctMjAyNi0xMS0xNi1lbg==/tiny/Research-and-Markets.png)

## Related

- [Healthcare Leaders Turn Months-Long Analyses Into Minutes With AI-Powered Growth Intelligence Platform](https://healthcarenews.io/news/healthcare-leaders-turn-months-long-analyses-into-minutes-with-ai-powered-growth-intellige.md)
- [Dental 3D Printing Market Size, Share, Growth, and Trends - Forecast to 2036 | Market to Reach USD 25.13 Billion at 17.2% CAGR, Led by Direct Fabrication and Materials Demand](https://healthcarenews.io/news/dental-3d-printing-market-size-share-growth-and-trends-forecast-to-2036-market-to-reach-us.md)
- [South Korea Osteopontin Market Trends and Forecast 2026-2035 | Biomarker Demand, Cancer Research, and Medical Applications Unlock Growth](https://healthcarenews.io/news/south-korea-osteopontin-market-trends-and-forecast-2026-2035-biomarker-demand-cancer-resea.md)
- [Rare Disease Clinical Trials - Global Strategic Business Report 2026: Capitalize on the $19.5 Billion Market as IQVIA, ICON, Parexel, and Labcorp Disrupt Trial Economics by 2032](https://healthcarenews.io/news/rare-disease-clinical-trials-global-strategic-business-report-2026-capitalize-on-the-19-5.md)
